Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer, with increased incidence in immunosuppressed patients. β-Human papillomavirus has been proposed as a contributor to cSCC risk partly on the basis of increased β-human papillomavirus viral load and seropositivity observed among patients with cSCC. Experimental data in mice colonized with mouse papillomavirus type 1 suggest that T cell immunity against β-human papillomavirus suppresses skin cancer in immunocompetent hosts, and the loss of this immunity leads to the increased risk of cSCC. In this study, we show that CD8(+) T cell depletion in mouse papillomavirus type 1âcolonized mice that underwent skin carcinogenesis protocol led to increased viral load in the skin and seropositivity for antiâmouse papillomavirus type 1 antibodies. These findings provide evidence that compromised T cell immunity can be the link that connects increased β-human papillomavirus detection to cSCC risk.
Compromised T Cell Immunity Links Increased Cutaneous Papillomavirus Activity to Squamous Cell Carcinoma Risk.
T细胞免疫功能受损与皮肤乳头瘤病毒活性增强和鳞状细胞癌风险增加有关
阅读:4
作者:Johnson Luke H, Son Heehwa G, Ha Dat Thinh, Strickley John D, Joh Joongho, Demehri Shadmehr
| 期刊: | JID Innovations | 影响因子: | 0.000 |
| 时间: | 2023 | 起止号: | 2022 Sep 29; 3(2):100163 |
| doi: | 10.1016/j.xjidi.2022.100163 | 研究方向: | 细胞生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
